Adaptimmune Therapeutics PLC (ADAPY) EBITDA Margin (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) posted EBITDA Margin of -203.11% for Q2 2025, down 258.82 percentage points from 55.71% a year earlier but up 390.81 percentage points from the prior quarter.
Adaptimmune Therapeutics PLC (ADAPY) EBITDA Margin (2015 - 2025) Analysis & Trends
For the trailing twelve months through Jun 30, 2025, EBITDA Margin at Adaptimmune Therapeutics was -235.99%, down 189.53 percentage points year-over-year; for FY2024, it was -32.32%, up 183.18 percentage points from FY2023.
- Annual EBITDA Margin has increased for five consecutive years, with a five-year change of +11711.00 percentage points (FY2019 to FY2024).
- In prior years, Adaptimmune Therapeutics' EBITDA Margin was -215.49% in FY2023 (+366.10 pp), -581.59% in FY2022 (+1950.19 pp), -2531.78% in FY2021 (+646.87 pp) and -3178.65% in FY2020 (+8564.66 pp).
- Quarterly EBITDA Margin has run from a low of -20339.83% in Q4 2023 to a high of 55.71% in Q2 2024 over five years.
- On a year-over-year basis, EBITDA Margin increased in four of the last eight quarters, with an average year-over-year change of -171.13 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2024, with a gain of 18146.03 percentage points; the weakest was Q4 2023, with a drop of 20105.83 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -593.92% (Q1 2025), -2193.79% (Q4 2024) and -29.00% (Q3 2024).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -203.11% |
| Mar 31, 2025 | -593.92% |
| Dec 31, 2024 | -2,193.79% |
| Sep 30, 2024 | -29.00% |
| Jun 30, 2024 | 55.71% |
| Mar 31, 2024 | -817.74% |
| Dec 31, 2023 | -20,339.83% |
| Sep 30, 2023 | -597.64% |
| Jun 30, 2023 | -831.89% |
| Mar 31, 2023 | 7.35% |
| Dec 31, 2022 | -234.00% |
| Sep 30, 2022 | -592.25% |
| Jun 30, 2022 | -762.01% |
| Mar 31, 2022 | -1,353.45% |
| Dec 31, 2021 | -2,933.45% |
| Sep 30, 2021 | -3,385.45% |
| Jun 30, 2021 | -1,223.55% |
| Mar 31, 2021 | -8,399.31% |
| Dec 31, 2020 | -2,382.69% |
| Sep 30, 2020 | -2,854.40% |
Adaptimmune Therapeutics PLC EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();